Sentences with phrase «on newer treatment»

We are working on newer treatment options to help keep your pets more comfortable.

A company that is working on new treatments for say children with cancer may develop an advisory board made up of pediatric oncologists and therapists.

Some thoughts on new treatments being investigated for Coeliac Disease, and the clinical trials required to bring them to market.

«This [new] study represents real progress in regenerative medicine and opens the door on new treatment options for people with age - related macular degeneration,» says Pete Coffey at the UCL Institute of Ophthalmology, part of the team who carried out the trial.

«Early diagnosis, effective therapy vital for treatment of deadly invasive aspergillosis: New guidelines focus on new treatments, early diagnosis of fungal infection.»

Ironically, the man is a member of the Australian team working on the new treatment.

A world patent (WO 98 / 43483) is pending on the new treatment, according to patent data service Derwent Information, and Phenex, a Toronto company, plans to market it.

When we learned about plans by the U.S. Department of Defense and other government agencies to focus on new treatments for our wounded warriors, we saw it as an opportunity to give back to those who put themselves in harm's way while serving our country.

A multi-disciplinary research program focusing on new treatments and diagnostics for lymphoid cancers

A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer.

The research presentations cover a wide range of disciplines, treatment approaches and cancer types, including a unique form of immunotherapy for ovarian cancer, promising results on a new treatment approach for Hodgkin lymphoma in children and young adults and an effort to build a predictive tool to determine which patients are most likely to respond well to checkpoint inhibitors.

Read current medical research on new treatment options, vaccines, surgery and prevention.

Read current medical research on new treatment options, vaccines, surgery and prevention.

The solutions examined were: fighting tuberculosis through drugs and improved case identification; getting cheap drugs that treat acute heart disease to developing countries; combining a malaria prevention package (mosquito nets, DDT spray, etc.) with subsidies on new treatments; expanding immunization and micronutrient coverage for children in developing nations; tobacco taxes in developing nations; and a multiple ‐ intervention approach to preventing and treating H.I.V. / AIDS; making investments in hospitals.

Read current medical research on new treatment options, vaccines, surgery and prevention.

Not exact matches

It was that skeptical mindset of questioning 18 th - century medical treatments that led Hahnemann to propose his new system, homeopathy, based on his «like cures like» theory.

TEL AVIV, May 2 - Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.

Merck is increasingly reliant on the blockbuster medicine, which is positioned to become the leading player in a new generation of oncology treatments and rival Bristol - Myers Squibb's Opdivo.

In a 564 - person trial, patients whose ovarian cancer recurred (and who had already started treatment with chemotherapy) given Rubraca, part of a new class of cancer drugs called «PARP» inhibitors, lived, on median, for double the amount of time without their disease getting even worse compared with those given a placebo.

With its traditional insulin treatments in the firing line due to U.S. price pressure, Novo Nordisk is pinning hopes for growth on new obesity drugs and a once - weekly injection and tablet version of its semaglutide drug.

Sanofi, a diabetes specialist which is now facing increased competition from rivals, has been on a mission to boost its treatment pipeline with new products for diseases that affect a wide swath of patients.

While it's been facing some sales problems on the former front, the biotech is now attempting to strengthen its position in the latter with solid new data for an HIV treatment cocktail combining bictegravir with emtricitabine / tenofovir alafenamide, two of its main drugs for the virus.

TEL AVIV, May 2 (Reuters)- Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.

On Wednesday, Swiss pharmaceutical giant Novartis made history as the first company to win Food and Drug Administration (FDA) approval for a groundbreaking new type of cancer treatment known as CAR - T.

A new social - hashtag campaign calls on everyone to demand that governments find a way to provide the resources to allow treatment for all those infected with AIDS.

And take heart that, even if treatment options seem to be coming to an end, if you can hold on a little longer, new treatments are continually discovered that might help.

The memory - eating disease, expected to afflict 15 million Americans by 2060 (and tens of millions more around the world as life expectancy increases), has no cure; a new drug for the condition hasn't been approved in well over a decade; initially promising experimental treatments seem to be failing with clockwork regularity; and there's not even a definitive consensus on what, exactly, biopharma companies should focus on while developing Alzheimer's medicines.

The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assistance programs to patients would: «force reporters to focus on the byzantine nature of drug pricing and health care and ensure the patient message gets out... specifically tie profits from Daraprim to the research and development of a new and more effective treatment for Daraprim patients.

But scientists are discovering more and more clues that suggest that the key to discovering new treatments for mental illnesses will center on a deeper dive into our DNA.

COPENHAGEN / BRUSSELS, Jan 8 - Denmark's Novo Nordisk, the world's biggest insulin maker, went public with a 2.6 billion euro bid for Belgian biotech group Ablynx on Monday, seeking a new source of growth by bolstering its treatments for rare blood disorders.

COPENHAGEN / BRUSSELS, Jan 8 - Denmark's Novo Nordisk, the world's biggest insulin maker, went public with a 2.6 billion euro bid for Belgian biotech group Ablynx on Monday as it seeks a new source of growth by bolstering its treatments for rare blood disorders.

The future of healthcare, according to Cuban, is technology that eliminates the middle man (namely doctors» offices and pharmacies) in the diagnosis and treatment process, the Shark Tank judge told Arianna Huffington onstage at Advertising Week in New York on Wednesday.

• Airway Therapeutics, a Cincinnati - based biotech firm focused on lung disease treatments, raised $ 11 million in Series B funding from new and existing investors.

Biotech giant Gilead Sciences is beefing up its cancer drug portfolio with a $ 11.9 billion deal to buy Kite Pharma, a company focused on a groundbreaking new class of treatments that turns the body's own immune cells into targeted blood cancer killers.

On Wednesday, the U.S. Food and Drug Administration approved Novartis» Kymriah, the first drug for a new kind of cancer treatment called CAR - T cell therapy.

December 1 was World AIDS Day, and a new social - hashtag campaign was launched, #TreatmentForAll, which calls on everyone around the world to demand that governments find a way to provide the resources to allow treatment for all those infected and offer the resources to stop the factors that are contributing to the spread of HIV and AIDS - related illnesses.

Herper homes in on a relatively new class of super-powerful (and super expensive) cholesterol - busting drugs called PCSK9 inhibitors (which were just shown to reduce death from any cause, and particularly heart - related conditions), and how patients with staggeringly high cholesterol who would benefit from the treatments had to wrangle with insurance companies that refused to cover them over their high prices.

As you might expect, representatives from these companies talked about the innovative technology on the market and they talked up their new benefits and perks, like genetic tests and fertility treatments.

So, Loncar took matters into his own hands and created a new type of biotech index that focuses exclusively on the red - hot field of cancer immunotherapy drugs (treatments which use the body's immune system as a conduit to fight cancer).

Sørensen displaced last year's No. 1, Jeff Bezos of Amazon (who's now No. 87 thanks to HBR's new methodology), in part because his company made the decision to focus almost exclusively on diabetes treatment, which has driven up the company's sales and stock price.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

On the other hand, the potential for profit is extraordinary if and when new treatment breakthroughs occur.

«The problem goes beyond new taxes on iPods and other electronic goods,» said Daniel Brock, a lawyer advising the Canadian Importers 9948 Fair Treatment Coalition («9948 Coalition»).

NEW YORK Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.

GSK, which plans to defend its patch with a new two - drug treatment regimen for controlling the virus behind AIDS, declined to comment further on Wednesday.

Those hawking such treatments depend on frightening parents into believing that their child has fallen victim to a terrifying new condition.

TEL AVIV Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums.

On February 15, 2018, tax attorneys Steven Toscher and Michel R. Stein, principals at Hochman Salkin Rettig Toscher & Perez P.C., delivered a presentation entitled «New IRS Scrutiny on Cryptocurrency Reporting: Filing Requirements and Exchange Treatment.&raquOn February 15, 2018, tax attorneys Steven Toscher and Michel R. Stein, principals at Hochman Salkin Rettig Toscher & Perez P.C., delivered a presentation entitled «New IRS Scrutiny on Cryptocurrency Reporting: Filing Requirements and Exchange Treatment.&raquon Cryptocurrency Reporting: Filing Requirements and Exchange Treatment.»

We are also encouraged to see $ 165 million allocated in this budget for mental health care funding, including $ 45 million for mental health counselling for children, $ 12 million for specialized addiction treatment, and $ 5 million in startup costs for the new B.C. Centre on Substance Use.

April 24 U.S. drugmaker Eli Lilly and Co reported a quarterly profit on Tuesday on higher demand for its newer treatments such as its diabetes drug Trulicity and psoriasis medicine Taltz.